Cambridge Institute for Medical Research

Our strategy

CIMR is a unique partnership between basic and clinical research, aiming to understand the cellular basis of disease. Our goal is to create an inspiring environment in which outstanding scientists can excel. By providing state-of-the-art core facilities and support for our researchers, we foster new collaborations that spark discoveries about fundamental cellular processes and their relevance in disease.

Research advances

The Siniossoglou group has collaborated with the Savage group (Institute of Metabolic Sciences) to elucidate a conserved biophysical mechanism for phospholipid sensing by the PCYT1 enzyme at the inner nuclear membrane.

Research advances

The St George-Hyslop group has collaborated with researchers in Departments of Chemistry, Chemical Engineering and PDN in a Cell study to determine the modifications of the RNA-binding protein FUS that regulate its phase separation.

2017 research report

2018 Academy of Medical Sciences Fellows

We are delighted that Jim Huntington has been elected as a Fellow of the Academy of Medical Sciences.

Roger de Spoelberch Prize

Many congratulations to David Rubinsztein, who has been awarded the 2017 Roger de Spoelberch prize for his contributions to neurodegeneration research.